Simvastatin in the Prevention of Recurrent Pancreatitis

NCT04021498 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

83

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment

Conditions

Pancreatitis Relapsing

Interventions

DRUG: Simvastatin 40mg
OTHER: Placebo

Sponsor

Enrique de-Madaria

Collaborators

[object Object]
[object Object]
[object Object]